hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Satellos Bioscience Inc.
Announced today the formation of a Clinical Advisory Board comprised of distinguished clinical research leaders and experts in drug development in genetic muscle disorders, including Duchenne muscular dystrophy. Satellos Bioscience Inc. shares T.MSCL are trading up $0.02 at $0.50.
